Apart from Aβ and tau biomarkers, blood-based indicators of neurodegeneration in AD include total tau, GFAP, and neurofilament light chain (NfL), reflecting neuronal injury, CNS inflammation, and subcortical axonal damage, respectively. This evidence concerns the gene GFAP and Alzheimer disease.